Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT01985425

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01985425
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01985425. Randomized; quadruple masking; primary purpose prevention. Start 2014-04 (registry gives no type); primary completion 2015-04 (actual). Results posted on 2017-01-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study
Acronym
COP-AF Pilot
Condition
Thoracic Surgery
Intervention (Drug)
Colchicine 0.6 mg
Intervention (Drug)
Placebo Colchicine
Lead sponsor
Population Health Research Institute (class: other)
Collaborator
Canadian Institutes of Health Research (CIHR) (class: other government)

Record details

Record id
cardio:ct-nct01985425
Content hash
ae32f97936ca51ab015ff9c0c45965e2fe67b530c84af01117c676179227b19a